FDA Moves Toward a Streamlined Regulatory Process for Artificial Intelligence

Retrieved on: 2019-04-11 01:15:00

Tags for this article:

Health

Pharmaceutical industry

Food and Drug Administration

Medical device

United States Public Health Service

Scott Gottlieb

Medical software

Office of In Vitro Diagnostics and Radiological Health

Christopher Ezold

Click the tags to see associated articles and topics

FDA Moves Toward a Streamlined Regulatory Process for Artificial Intelligence. View article details on hiswai:

Excerpt

<div>Using <b>artificial intelligence</b> (AI) (smart machines that are developed to do work normally done by humans) and machine learning (ML) (machines that ...</div>

Article found on:

View Original Article